TLSI
TriSalus Life Sciences Inc.
4.40$
+1.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 11.3% | 10.2% | 15.0% | 12.4% | 13.7% | 14.7% | 16.3% | 16.1% | 16.5% | 13.3% | 13.8% | 13.2% | 14.2% | |
| 88.7% | 89.8% | 85.0% | 87.6% | 86.3% | 85.3% | 83.7% | 83.9% | 83.5% | 86.7% | 86.2% | 86.8% | 85.8% | |
| 183.1% | 133.5% | 90.7% | 63.4% | 57.4% | 35.8% | 36.0% | 35.0% | 44.8% | 19.5% | 36.1% | 27.5% | 31.3% | |
| 173.8% | 105.1% | 71.7% | 53.7% | 64.3% | 141.2% | 54.2% | 50.5% | 57.6% | 31.6% | 61.3% | 45.2% | 47.6% | |
| 447.1% | 336.6% | 265.9% | 198.6% | 205.3% | 191.8% | 163.6% | 149.3% | 161.5% | 111.4% | 180.7% | 172.8% | 153.5% | |
| -358.5% | -246.8% | -181.0% | -111.0% | -118.9% | -91.8% | -79.9% | -65.4% | -77.9% | -24.8% | -94.5% | -86.0% | -67.7% | |
| 0.1% | 0.1% | 0.0% | 11.9% | 15.5% | 12.9% | 13.2% | 12.7% | 12.6% | 11.0% | 16.1% | 13.1% | 13.0% | |
| -27.4% | -620.7% | -204.7% | -58.7% | -32.7% | -122.4% | -113.1% | -73.9% | -93.4% | -73.9% | 17.3% | -80.5% | -62.6% | |
| -2.2% | 0.0% | 0.0% | 0.1% | 0.0% | – | 0.1% | 0.0% | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | |
| -27.4% | -620.7% | -204.7% | -58.8% | -32.6% | -122.4% | -113.2% | -73.9% | -93.5% | -73.9% | 17.3% | -80.5% | -62.6% | |
| -24.4% | -617.1% | -201.7% | -44.0% | -14.8% | – | -98.1% | -59.8% | -79.4% | -61.9% | 35.0% | -65.1% | -48.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.